Clifford Swan Investment Counsel’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.9M | Buy |
|
|||||
|
2025
Q1 | $13.2M | Sell |
|
|||||
|
2024
Q4 | $16.4M | Sell |
|
|||||
|
2024
Q3 | $23.1M | Sell |
|
|||||
|
2024
Q2 | $27.9M | Sell |
|
|||||
|
2024
Q1 | $25.6M | Sell |
|
|||||
|
2023
Q4 | $21.8M | Sell |
|
|||||
|
2023
Q3 | $19.3M | Sell |
|
|||||
|
2023
Q2 | $17.3M | Sell |
|
|||||
|
2023
Q1 | $17.3M | Sell |
|
|||||
|
2022
Q4 | $15M | Sell |
|
|||||
|
2022
Q3 | $11.2M | Sell |
|
|||||
|
2022
Q2 | $12.7M | Sell |
|
|||||
|
2022
Q1 | $12.7M | Sell |
|
|||||
|
2021
Q4 | $12.8M | Sell |
|
|||||
|
2021
Q3 | $12.7M | Buy |
|
|||||
|
2021
Q2 | $11.3M | Sell |
|
|||||
|
2021
Q1 | $7.86M | Sell |
|
|||||
|
2020
Q4 | $8.26M | Sell |
|
|||||
|
2020
Q3 | $8.4M | Sell |
|
|||||
|
2020
Q2 | $8.17M | Sell |
|
|||||
|
2020
Q1 | $7.67M | Sell |
|
|||||
|
2019
Q4 | $7.56M | Sell |
|
|||||
|
2019
Q3 | $7.26M | Sell |
|
|||||
|
2019
Q2 | $7.39M | Sell |
|
|||||
|
2019
Q1 | $8.52M | Sell |
|
|||||
|
2018
Q4 | $8.03M | Sell |
|
|||||
|
2018
Q3 | $8.59M | Sell |
|
|||||
|
2018
Q2 | $9.26M | Sell |
|
|||||
|
2018
Q1 | $11.2M | Sell |
|
|||||
|
2017
Q4 | $15M | Buy |
|
|||||
|
2017
Q3 | $13M | Sell |
|
|||||
|
2017
Q2 | $11.8M | Sell |
|
|||||
|
2017
Q1 | $10.1M | Buy |
|
|||||
|
2016
Q4 | $10.2M | Buy |
|
|||||
|
2016
Q3 | $10.7M | Buy |
|
|||||
|
2016
Q2 | $11.9M | Sell |
|
|||||
|
2016
Q1 | $12.1M | Sell |
|
|||||
|
2015
Q4 | $13M | Sell |
|
|||||
|
2015
Q3 | $12.2M | Sell |
|
|||||
|
2015
Q2 | $12.4M | Sell |
|
|||||
|
2015
Q1 | $12.7M | Buy |
|
|||||
|
2014
Q4 | $8.29M | Buy |
|
|||||
|
2014
Q3 | $9.3M | Sell |
|
|||||
|
2014
Q2 | $9.03M | Sell |
|
|||||
|
2014
Q1 | $9.07M | Buy |
|
|||||
|
2013
Q4 | $7.29M | Buy |
|
|||||
|
2013
Q3 | $2.5M | Buy |
|
|||||
|
2013
Q2 | $494K | Buy |
|